CAR-T SEAKER Cells Activate Small Molecule Drugs at Tumor Site

CAR-T cells, engineered to act as cancer drug "micropharmacies," could address challenges with eliminating tumor masses and toxicity.

Related Keywords

Charles Nicolette ,David Scheinberg , ,Nature Chemical Biology ,Memorial Sloan Kettering Cancer Center ,Sloan Kettering Institute ,Synthetic Enzyme Armed ,Derek Tan ,